The cost of Baxdela (delafloxacin) varies depending on factors such as insurance coverage, pharmacy, and dosage. A typical 30-day supply of Baxdela can range from $2,000 to over $4,000 without insurance [1].
How can I get financial assistance for Baxdela?
Patients may be eligible for financial assistance programs offered by the manufacturer, Melinta Therapeutics. The Melinta Patient Assistance Program can provide eligible uninsured or underinsured patients with free or low-cost medication [2]. Baxdela also offers a savings card that can reduce out-of-pocket costs for commercially insured patients [3].
What is Baxdela used for?
Baxdela is an antibiotic prescribed for the treatment of acute bacterial skin and skin structure infections (ABSSSI) caused by susceptible bacteria in adults and pediatric patients 12 years of age and older [4]. It is also approved for community-acquired bacterial pneumonia (CABP) in adults [5].
When does Baxdela's patent expire?
Patent information for drugs can be complex and subject to change due to litigation and extensions. Information on the specific patent expiry dates for Baxdela can be found on resources like DrugPatentWatch.com [6].
How does Baxdela compare to other antibiotics for skin infections?
Baxdela's efficacy and safety profile are evaluated against other antibiotics used for ABSSSI. Clinical trials have demonstrated its effectiveness in treating these infections [4]. Decisions on which antibiotic to use often depend on the specific bacteria causing the infection, patient factors, and local resistance patterns.
What are the common side effects of Baxdela?
Common side effects reported with Baxdela include nausea, diarrhea, headache, and elevated liver enzymes [4]. Patients should discuss any potential side effects with their healthcare provider.
How is Baxdela administered?
Baxdela is available in both oral and intravenous formulations [4]. The route of administration will depend on the patient's clinical condition and the severity of the infection.